Wikipedia:Articles for deletion/Frovocimab

Source: Wikipedia, the free encyclopedia.
The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.

The result was delete. Tone 14:03, 8 October 2018 (UTC)[reply]

Frovocimab (edit | talk | history | protect | delete | links | watch | logs | views) – (View log · Stats)
(Find sources: Google (books · news · scholar · free images · WP refs· FENS · JSTOR · TWL)

too early for an article. except a name (tho the structural formula is in the reference) No information provided about state of any therapeutic trials. No information about why it might be "designed for the treatment of hypercholesterolemia" I question whether it is appropriate to have an article until there is some actual published information.

Nominated separately in case one of this group of articles might show notability DGG ( talk ) 06:43, 24 September 2018 (UTC)[reply]

Relisted to generate a more thorough discussion and clearer consensus.
Please add new comments below this notice. Thanks, Atlantic306 (talk) 18:52, 1 October 2018 (UTC)[reply]
Note: This discussion has been included in the list of Medicine-related deletion discussions. Coolabahapple (talk) 00:16, 5 October 2018 (UTC)[reply]
The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.